IDEAS STUDY: IMAGING DEMENTIA- Evidence of Amyloid Screening

This study is being conducted with the American College of Radiology Imaging Network and the Alzheimer's Association to guide clinicians on how best to use amyloid PET imaging in the evaluation of people with cognitive decline. To be eligible for the IDEAS Study, patients must be Medicare beneficiaries 65 years of age or older with Medicare as their primary insurance source and must meet the Appropriate Use Criteria for amyloid PET imaging. A patient may be eligible for the IDEAS Study if there is diagnostic uncertainty after a comprehensive clinical evaluation by a dementia expert, including laboratory tests (complete blood count, comprehensive metabolic panel, thyroid function tests and vitamin B12 level) and structural brain imaging (CT or MRI).

Primary Sponsor:
American College of Radiology

Prinicipal Investigator:
Tania Alchalabi, MD and Christina Prather, MD/Geriatics & Palliative Care

Are you interested in more information on this clinical trial?

First Name *
Last Name *
Email *
Street Address *
City *
State *
Zip Code *
Phone Number 
Verification Code *

Please type what you see (all uppercase):